Gilead Sciences drug Trodelvy modestly delays breast cancer progression in late-stage trial Ruchika Sharma6 Jun 2022 4:09 PM ISTWall Street analysts, on average, expect annual sales of the drug will top $2 billion 2026, according to Refinitiv.
Novartis Kymriah gets USFDA nod for relapsed or refractory follicular lymphoma Ruchika Sharma30 May 2022 12:19 PM IST"Kymriah is now FDA approved in three indications and remains the only CAR-T cell therapy approved in both adult and pediatric settings," claims the...
Eli Lilly Kinsale gets CDSCO panel nod to import, market anticancer drug Selpercatinib Dr. Divya Colin20 May 2022 5:52 PM ISTNew Delhi: Granting the clinical trial waiver, the Subject Expert Committee ( SEC) of the Central Drugs Standard Control Organization (CDSCO) has...
Gland Pharma launches cancer drug Bortezomib in US Ruchika Sharma5 May 2022 12:06 PM ISTHyderabad: Gland Pharma Limited, a generic injectable focused pharmaceutical company, through its partner has launched Bortezomib for Injection, 3.5 ...
Aurobindo Pharma arm bags USFDA nod for cancer drug Bortezomib Ruchika Sharma4 May 2022 11:00 AM ISTHyderabad: Drugmaker, Aurobindo Pharma Limited, has recently announced that its wholly owned subsidiary company, Eugia Pharma Specialties...
AstraZeneca to study cancer drug Datopotamab deruxtecan in India Medical Dialogues Team27 Dec 2021 6:39 PM ISTNew Delhi: In a significant development, major drug-maker AstraZeneca has got the go ahead from the Subject Expert Committee (SEC) functional under...
AstraZeneca receives CDSCO panel nod to conduct phase 3 trial of Trastuzumab Deruxtecan Roshni Dhar1 Dec 2021 3:47 PM ISTIn a significant development, major drug-maker AstraZeneca has got the go ahead from the Subject Expert Committee (SEC) functional under the Central...
Health Bulletin 30/November/2021 Roshni Dhar30 Nov 2021 5:38 PM ISTHere are top Health stories of the dayCourt junks plea of 2 Accused in PGIMER MD seat scam, finds Prima Facie Case against 27In the latest development...
AstraZeneca gets CDSCO panel nod to conduct cancer drug Trastuzumab Deruxtecan study Medical Dialogues Team29 Nov 2021 6:21 PM ISTNew Delhi: In a significant development, major drug-maker AstraZeneca has got the go ahead from the Subject Expert Committee (SEC) functional under...
Erbitux, adagrasib combination shrinks tumors in 39 percent of colon cancer patients: Mirati Therapeutics Ruchika Sharma20 Sept 2021 10:15 AM ISTNew Delhi: A combination of Mirati Therapeutics Inc's genetic mutation-targeting adagrasib and older cancer drug Erbitux shrank tumors in 39% of...
Reduced GST rates on COVID drugs extended till December Ruchika Sharma18 Sept 2021 5:44 PM ISTLucknow: The GST Council on Friday extended concessional tax rates on COVID-19 medicines, cut tax on cancer drugs and waived GST on import of highly...
Sun Pharma gets CDSCO panel nod to additional pack size of Gemcitabine Medical Dialogues Team16 Aug 2021 2:00 PM ISTNew Delhi: Pharmaceutical major, Sun Pharma has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
